Sea Moss for Primary Sclerosing Cholangitis: Anti-Inflammatory, Th17/IL-17 Bile Duct Autoimmunity & Mineral Support

Primary sclerosing cholangitis (PSC) is a progressive fibro-inflammatory cholestatic liver disease driven by CD4+ Th17/IL-17/NF-kB bile duct inflammation, TGF-beta1/SMAD periductal 'onion-skin' fibrosis, HLA-B8/DR3 susceptibility, gut microbiome dysbiosis (IBD in ~70%), gut-liver axis bacterial translocation via portal vein, VCAM-1/ICAM-1 endothelial activation, elevated alkaline phosphatase/gamma-GT, and biliary strictures/dilation causing cholestasis, cholangitis episodes, and cholangiocarcinoma risk (~10-15% lifetime). Sea moss fucoidan modulates NF-kB, IL-17, TGF-beta1/SMAD fibrosis, and complement; selenium supports biliary GPx1/GPx4 oxidative stress defense; omega-3 DHA modulates biliary eicosanoid balance and resolvin D1; zinc supports biliary MMP metalloenzymes and FOXP3+ Treg. No FDA-approved medical therapy; UDCA controversial; liver transplant definitive for end-stage. Sea moss as nutritional adjunct only.

Read the full guide